Product

Class

Target

Clinical Stage

Manufacturer

PTK787

Kinase inhibitor

VEGFR tyrosine kinase inhibitor

Phase II

Novartis

RSR13

(Efaproxiral)

Small molecule

Sensitize hypoxic areas of tumors

Phase II

Allos